bt/data/attachment/portal/202108/14 |
您所在的位置：网站首页 › bt/data/attachment/portal/202108/14 |
data-id="" >europa.euhttps://www.ema.europa.eu/en/documents/procedural...[PDF]Tysabri - European Medicines Agency网页2024年3月25日 · 202108 Periodic Safety Update EU Single assessment - natalizumab 24/03/2022 30/05/2022 SmPC Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)’ for PSUSA/2127/202108. II/0132 B.II.b.3.c - Change in the manufacturing process of the finished or intermediate product - …
发布时间：2024-05-05